This phase 1/phase 2 trial is enrolling individuals with incomplete chronic cervical and thoracic spinal cord injuries to test the effect of a drug (Rimonabant) on walking ability. If included, participants will either take: 1) two pills of placebo; 2) one pill of placebo and one pill of Rimonabant (2.5mg); or 3) two pills of Rimonabant (5mg) once per day for 5 consecutive days. Final testing will be performed after 15 days.
Traumatic
Type
Details
Participants will receive either 1) two pills of placebo, 2) one pill of placebo and one pill of Rimonabant (2.5mg) or 3) two pills of Rimonabant once per day on 5 consecutive days.
Main benefits
Standing/walking/mobility
Additional benefits
General health
Mental health and psychosocial factors
Pain
Spasticity
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more